DFX Intelligence
Venture Capital Intelligence
Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.
Firms / Dcvc Bio
Dcvc Bio
One of 2 advisers that share dcvc.com; the firm is DCVC. Dcvc. Each keeps its own CRD, funds and filings; the grouping is the website each swore to on Form ADV and is recomputed every pass.
both early and growth/opportunity families, reported GAV $1,198M
Importance
32
moderate
Active deployment
29
moderate
Emerging
0
low
Completeness
63
high
Freshness
99
high
Research priority
13
low
Identity and regulatory footprint
- Headquarters
- Palo Alto, CAadviserinfo.sec.gov
- Office address
- 270 UNIVERSITY AVENUE, Palo Alto, CA, 94301adviserinfo.sec.gov
- Business phone
- 415-840-7337adviserinfo.sec.gov
- Website
- http://www.dcvc.com
- SEC adviser type
- exempt reporting adviseradviserinfo.sec.gov
- SEC exemption claimed
- venture capital fund adviseradviserinfo.sec.govItem 2.B(1): advises solely venture capital funds
- Latest Form ADV
- Mar 31, 2026
- Private funds reported
- 4 (4 venture capital funds)adviserinfo.sec.gov
- Private fund gross assets
- $1.0Badviserinfo.sec.govreported GAV of the funds, the adviser's own number; not fund size, not dry powder
- Owners on Schedule A
- ZNM Capital Management, LLC (Member), D; JNK Capital Management, LLC (Member), D
- business phone
- 415-840-7337adviserinfo.sec.govpublished by the subject
Stated thesis versus observed behaviour
1 observed deals
Stated (the firm’s website)
- Sectors
- not stated or not yet read
- Stages
- not stated or not yet read
- Geography
- not stated
- Check size
- not stated; DFX does not estimate checks from round sizes
Observed (from deals on record)
Stage at participation
series b 100%
Stage at first entry
series b 100%
Sectors
Agriculture 100%
lead rate 0%follow-on rate 0%new logos, 12 months 1
Funds and vehicles
4 reported
| Vehicle | Type | Vintage | Lifecycle | Reported GAV | Owners | Form D sold | Latest Form D |
|---|---|---|---|---|---|---|---|
| Dcvc Bio III, L.P. | Fund | 2024 adv first reported | Early deployment | $339M Mar 29, 2024 | 31 | $0 of $400M | Sep 28, 2023 |
| Dcvc Bio Opportunity Fund, L.P. | Opportunity fund | 2022 adv first reported | Active deployment | $190M Mar 29, 2024 | 34 | $0 of $350M | Nov 18, 2021 |
| Dcvc Bio II, L.P. | Fund | 2020 form d first sale | Mature | $341M Mar 29, 2024 | 33 | $350M of $350M | Aug 4, 2020 |
| Dcvc Bio, L.P. | Fund | 2018 form d first sale | Harvest | $328M Mar 29, 2024 | 41 | $208M of $250M | May 14, 2019 |
GAV is the gross asset value the adviser reported on Form ADV for the vehicle, never the fund’s committed size and never dry powder. Form D sold is the amount sold as of the latest filing, never a final close.
Investment team
13 current, 2 departed
John Hamer
Managing partnerManaging Member · since Mar 1, 2018
John Hamer
Managing partnerManaging Member · since Mar 1, 2018
Kiersten Stead
Managing partnerManaging Member · since Feb 1, 2018
Kiersten Stead
Managing partnerManaging Member · since Feb 1, 2018
Matthew Ocko
Managing partnerManaging Member · since Feb 1, 2018
Matthew Ocko
Managing partnerManaging Member · since Feb 1, 2018
Zachary Bogue
Managing partnerManaging Member · since Feb 1, 2018
Zachary Bogue
Managing partnerManaging Member · since Feb 1, 2018
Justin Kern
PartnerPartner
Ryan T Ward
Platform and operationsChief Legal Officer · since Sep 1, 2022
Ryan T Ward
Platform and operationsChief Legal Officer · since Sep 1, 2022
Spencer Cochrane Punter
Platform and operationsChief Operating Officer · since Mar 1, 2018
Spencer Cochrane Punter
Platform and operationsChief Operating Officer · since Mar 1, 2018
2 departed (kept with end dates)
- Jocelyn Marie Serrescooke · Chief Financial Officer · Mar 1, 2018 to Mar 29, 2019 Inference
- Scott James · General Counsel · Aug 1, 2018 to Mar 31, 2023 Inference
Investments on record
1 edges, 1 companies, 1 partner-attributed
| Company | Round | Role | Partner | Round size | This investor | Date | Source |
|---|---|---|---|---|---|---|---|
| AgZen | Series B · Series B | participant | Justin Kern (confirmed) | $10.0M | unknown | Mar 13, 2026 | Fact Press release wires (Business Wire, PR Newswire, GlobeNewswire public RSS) |
“This investor” is the amount disclosed for this investor alone; it is unknown unless a source said it. The round size is the whole round.
Co-investors
40 relationships from shared deals, counted for the whole firm
Institutional Venture 3 shared · recurring137 Ventures Management, LLC 3 shared · recurringNightdragon Management Company, LLC 3 shared · recurringKhosla Ventures, LLC 3 shared · recurringInnovation Endeavors: Reimagining the technical frontier 2 shared · recurringGreat Oaks Management Company LLC 2 shared · recurringCanaan Partners 2 shared · recurringMadrona Venture Group, LLC 2 shared · recurringGlynn Capital Management, LLC 2 shared · recurringPrime Movers Lab LLC 2 shared · recurringWebb Investment Network Management, LLC 2 shared · recurringBlackbird Ventures Pty Ltd. 2 shared · recurringIcon Ventures 2 shared · recurringTenoneten 2 shared · recurringSpider Capital 2 shared · recurringDorm Room Fund 2 shared · recurringSapphire Ventures, LLC 2 shared · recurringLUX Capital Management, LLC 2 shared · recurringBling Capital LLC 2 shared · recurringAIM Master I (bvi) Ltd. 2 shared · recurringEthos Manager LLC 2 shared · recurringEmergence Equity Management, Inc 2 shared · recurringPascal Capital, L.L.C. 2 shared · recurringEpsilon Health Investors, LLC 1 shared · one timeAlpha Partners Management, LLC 1 shared · one timeHuman Capital 1 shared · one timeMPM Bioimpact 1 shared · one timeCollaborative Fund Management LLC 1 shared · one timeCompound Advisors, LLC 1 shared · one timeIselect Fund Management, LLC 1 shared · one timePillar Companies Management, LLC 1 shared · one timeBoot64 Ventures LLC 1 shared · one timeQuest Venture Partners 1 shared · one timeMaterial Impact Management, LLC 1 shared · one timeIA Capital Group, Inc. 1 shared · one timeInvivium Capital 1 shared · one timeMillennium Technology Value Partners 1 shared · one timeRadical Ventures 1 shared · one timeLeap Global Partners 1 shared · one timeHOF Capital 1 shared · one time
Limited partners
0 disclosed
No LP commitment on record. An LP edge needs a public disclosure with a quote: a pension report (see Limited partners for the plans read), a fund announcement naming the LP, or a Form ADV owner. The fund page carries the LP’s reported performance.
Timeline
10 dated events
- Sep 15, 2026Dcvc Bio: INSTITUTIONAL_VC -> MULTI_STAGE_VC (both early and growth/opportunity families, reported GAV $1,198M)Classification changedClassificationInferenceno URL
- Mar 29, 2024Dcvc Bio III, L.P. first reported on Form ADV by Dcvc Bio (Venture Capital Fund), GAV $338,504,267Fund first reported on Form ADVFundsFactDcvc Bio III, L.P.SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 31, 2023Scott James (General Counsel) no longer on Schedule A of Dcvc Bio
- Sep 1, 2022Ryan T Ward joined Schedule A of Dcvc Bio as Chief Legal Officer
- Mar 29, 2022Dcvc Bio Opportunity Fund, L.P. first reported on Form ADV by Dcvc Bio (Venture Capital Fund), GAV $165,668,056Fund first reported on Form ADVFundsFactDcvc Bio Opportunity Fund, L.P.SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Apr 1, 2021Dcvc Bio II, L.P. first reported on Form ADV by Dcvc Bio (Venture Capital Fund), GAV $351,157,922Fund first reported on Form ADVFundsFactDcvc Bio II, L.P.SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 29, 2019Jocelyn Marie Serrescooke (Chief Financial Officer) no longer on Schedule A of Dcvc Bio Management Co, LLC
- Aug 1, 2018Scott James joined Schedule A of Dcvc Bio Management Co, LLC as General Counsel
- Jun 19, 2018Dcvc Bio Management Co, LLC first filed Form ADV (ERA, venture capital fund adviser exemption)First SEC adviser filingOrganizationFactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Jun 19, 2018Dcvc Bio, L.P. first reported on Form ADV by Dcvc Bio Management Co, LLC (Venture Capital Fund), GAV $75,300,000Fund first reported on Form ADVFundsFactDcvc Bio, L.P.SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Classification history
- Sep 15, 2026Multi-stage venture firm (confirmed, 95%, cls-1)both early and growth/opportunity families, reported GAV $1,198M
- Sep 12, 2026Institutional venture firm (confirmed, 95%, cls-1)venture manager, reported GAV $857M across 3 vehicles
Evidence
37 observations from 3 sources